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INTRODUCTION
Prostate cancer (PCa) is the most common male malignancy and the second leading cause of cancer death among men in the United States. Although significant gains have been made in the management of the early phases of prostate cancer, the evolution of prostate cancer to a hormone-independent stage invariably signals advanced metastatic disease, with limited therapeutic options and poor prognosis (1) . Metastasis involves multiple sequential steps 
Survivin is a direct target of miR-203
The ability of miR-203 to impede multiple steps in the progression and metastasis of prostate cancer might derive from its ability to pleiotropically regulate genes involved in diverse aspects of metastatic dissemination. To identify effectors of miR-203, we used two algorithms that predict the mRNA targets of a miRNA, miRANDA (13) and TargetScan (14) . Guided by the target prediction algorithms, we found that miR-203 regulates a cohort of genes which play a
Research. co-staining with α-tubulin in the transfectants revealed a disorganized tubulin cytoskeleton in the miR-203 expressing cells compared to control cells (Fig. 5D ).
miR-203 regulates a cohort of metastatic genes
We performed Western blot analysis for other putative miR-203 targets in PC3 cells that were either mock tranfected or transfected with miR-203 or miR-CON (Fig. 6A) . Interestingly, miR-203 repressed the protein levels of E-box-binding transcription factor ZEB2, also known as Smad-interacting protein 1 (SIP1), a transcriptional repressor that regulates the expression of Ecadherin and EMT (18, 19 Since loss of miR-203 expression is a late event in prostate cancer progression, we propose that its effects on cellular proliferation and apoptosis may be relevant to the development of distant metastases.
Further, we demonstrate that miR-203 can pleiotropically regulate a cohort of metastatic effectors that includes apart from ZEB2, Bmi1 and Survivin. miR̂203 represents a 'stemnessinhibiting miRNA' as it was shown to control the properties of skin stem cells through inhibition of the stem cell factor p63 (27, 28) . Another recent study shows that ZEB1 regulates tumorigenesis by repressing stemness-inhibiting miRNAs, including miR-203 in pancreatic cancer (29) . It has been suggested that the same miRNAs may be involved in invasion and metastasis of tumor cells and in maintenance of the cancer stem cell phenotype, possibly accounting for the thread of malignancy connecting primary to metastatic tumors (8) . In view of our present results suggesting a role of miR-203 in metastasis and miR-203 mediated inhibition of stem cell factor, Bmi1, we hypothesize that miR-203 supports metastasis not only by promoting metastasis relevant traits; but also by maintaining a stem cell phenotype, which is necessary for the formation of metastasis from disseminated tumor cells.
miR-203 mediated regulation of survivin is a highly significant finding as this nodal protein orchestrates extensive, tumor specific signaling networks and is an attractive drug target (30) .
Recent studies suggest a direct role of survivin in cancer progression and metastasis (16, 17) . In prostate cancer, survivin is a significant contributor to the development of hormone resistance in prostate cancer and is associated with unfavorable outcome. It has been hypothesized that targeting survivin and blocking it would enhance prostate cancer cell susceptibility to antiandrogen therapy (31).
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